Therapeutic potential of TGF-β inhibition in chronic renal failure

被引：35
|
作者：
Gagliardini, Elena [1 ]
Benigni, Ariela [1 ]
机构：
[1] Mario Negri Inst Pharmaceut Res, I-24125 Bergamo, Italy
来源：
EXPERT OPINION ON BIOLOGICAL THERAPY | 2007年 / 7卷 / 03期
关键词：
progressive nephropathies; proteinuria; renal fibrosis; transforming growth factor-beta;
D O I：
10.1517/14712598.7.3.293
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
Chronic kidney diseases are emerging as a worldwide public health problem. The progression of kidney diseases closely correlates with the accumulation of extracellular matrix leading to glomerulosclerosis and tubulointerstitial injury. Transforming growth factor (TGF)-beta has been identified as a key mediator of kidney matrix accumulation. Overexpression of TGF-beta isoforms and their receptors was observed in a variety of renal diseases in both animals and humans. Given its crucial role in fibrotic kidney disease, TGF-beta has been recently considered as a possible target in the management of chronic renal diseases. This review discusses the role of TGF-beta in renal fibrosis and provides an overview of the strategies that, when interfering with TGF-beta expression and signalling, could be employed as new renoprotective treatments.
引用
收藏
页码：293 / 304
页数：12
相关论文
共 50 条
  • [21] Inhibition of TGF-β and VEGF expression in human endothelium cell lines with antisense-oligonucleotides:: Potential tools for gene therapy of chronic renal transplant rejection
    Hallscheidt, P
    Wallich, R
    Kauffmann, GW
    Pomer, S
    TRANSPLANTATION PROCEEDINGS, 2001, 33 (03) : 2157 - 2159
  • [22] Effect of Bushen Qudu Decoction on TGF-β1/Smads signal transduction pathway in rats with chronic renal failure
    Shi, Weirong
    Wu, Qiang
    Wu, Qiuhong
    Tang, Juan
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2022, 21 (03) : 555 - 561
  • [23] TGF-β in cancer and as a therapeutic target
    Pinkas, Jan
    Teicher, Beverly A.
    BIOCHEMICAL PHARMACOLOGY, 2006, 72 (05) : 523 - 529
  • [24] TGF-β signaling pathway in spinal cord injury: Mechanisms and therapeutic potential
    Ma, Chun-wei
    Wang, Zhi-qiang
    Ran, Rui
    Liao, Hai-yang
    Lyu, Jia-yang
    Ren, Yi
    Lei, Ze-yuan
    Zhang, Hai-hong
    JOURNAL OF NEUROSCIENCE RESEARCH, 2024, 102 (01)
  • [25] TGF-β-induced fibrosis: A review on the underlying mechanism and potential therapeutic strategies
    Ong, Chun Hao
    Tham, Chau Ling
    Harith, Hanis Hazeera
    Firdaus, Nazmi
    Israf, Daud Ahmad
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2021, 911
  • [26] In silico identification of potential therapeutic targets in the TGF-β signal transduction pathway
    Nicklas, Daniel
    Saiz, Leonor
    MOLECULAR BIOSYSTEMS, 2014, 10 (03) : 537 - 548
  • [27] TGF-β Modulated Pathways in Colorectal Cancer: New Potential Therapeutic Opportunities
    Fasano, Morena
    Pirozzi, Mario
    Miceli, Chiara Carmen
    Cocule, Mariateresa
    Caraglia, Michele
    Boccellino, Mariarosaria
    Vitale, Pasquale
    De Falco, Vincenzo
    Farese, Stefano
    Zotta, Alessia
    Ciardiello, Fortunato
    Addeo, Raffaele
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (13)
  • [28] The Role of TGF-β Signaling Pathways in Cancer and Its Potential as a Therapeutic Target
    Yang, Yun
    Ye, Wen-Long
    Zhang, Ruo-Nan
    He, Xiao-Shun
    Wang, Jing-Ru
    Liu, Yu-Xuan
    Wang, Yi
    Yang, Xue-Mei
    Zhang, Yu-Juan
    Gan, Wen-Juan
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2021, 2021
  • [29] TGF-β Inhibition and Immunotherapy: Checkmate
    Ganesh, Karuna
    Massague, Joan
    IMMUNITY, 2018, 48 (04) : 626 - 628
  • [30] Inhibition of TGF-β1 might be a novel therapeutic target in the treatment of cardiac fibrosis
    Wang, Wei
    Wang, Chunsong
    Li, Lin
    Sun, Peng
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 256 : 19 - 19
12345